Top Page
SiriusPoint
(NYSE:SPNT)
SiriusPoint (SPNT) vs. SPDR S&P 500 ETF (SPY)
SiriusPoint Business Overview & Revenue Model
SiriusPoint Earnings Call Summary
SiriusPoint Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.65B | 2.60B | 2.70B | 2.11B | 2.22B | 884.57M |
| Gross Profit | 1.18B | 2.66B | 848.40M | 2.08B | 2.13B | 7.83M |
| EBITDA | 224.20M | 314.60M | 393.90M | -370.20M | 4.64B | 160.10M |
| Net Income | 169.70M | 199.90M | 354.80M | -386.00M | 58.10M | 143.80M |
Balance Sheet | ||||||
| Total Assets | 12.36B | 12.52B | 12.87B | 11.04B | 10.62B | 3.54B |
| Cash, Cash Equivalents and Short-Term Investments | 5.66B | 6.03B | 6.10B | 4.33B | 2.08B | 525.99M |
| Total Debt | 706.40M | 639.10M | 786.20M | 778.00M | 816.70M | 114.27M |
| Total Liabilities | 10.25B | 10.59B | 10.34B | 8.95B | 8.12B | 1.97B |
| Stockholders Equity | 2.11B | 1.94B | 2.51B | 2.07B | 2.50B | 1.56B |
Cash Flow | ||||||
| Free Cash Flow | 135.10M | 74.70M | 581.30M | 292.50M | 1.60M | 73.36M |
| Operating Cash Flow | 135.10M | 74.70M | 581.30M | 293.30M | 1.60M | 73.36M |
| Investing Cash Flow | 970.60M | 343.60M | -332.20M | -1.30B | 208.60M | 6.11M |
| Financing Cash Flow | -906.50M | -625.00M | -61.50M | -23.70M | 24.30M | -19.48M |
SiriusPoint Technical Analysis
SiriusPoint Risk Analysis
SiriusPoint Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $2.46B | 6.56 | 15.86% | ― | 28.86% | -11.22% | |
| ― | $11.46B | 6.21 | 18.75% | 0.66% | 23.19% | -22.42% | |
| ― | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
| ― | $12.52B | 16.48 | 7.07% | 1.90% | 1.53% | -10.27% | |
| ― | $2.14B | 20.61 | 4.82% | ― | -4.56% | -55.48% | |
| ― | $417.56M | 11.16 | 5.82% | ― | 2.18% | -41.11% | |
| ― | $13.06M | -3.72 | -58.30% | ― | ― | 78.09% |
SiriusPoint Corporate Events
On October 13, 2025, SiriusPoint Ltd. announced the resignation of Evan Cabat, the Chief Accounting Officer, effective October 31, 2025, as he pursues another opportunity. The company clarified that his departure is not due to any disagreements regarding financial or operational matters. Jim McKinney, the Chief Financial Officer, will take over Cabat’s responsibilities, ensuring continuity in the company’s financial leadership.
The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
On October 3, 2025, SiriusPoint Ltd. announced the sale of its 49% equity stake in Arcadian Risk Capital to Lee Equity Partners for $139 million, with the transaction expected to close by the first quarter of 2026. The deal includes an extension of SiriusPoint’s capacity agreement with Arcadian until 2031, and upon completion, SiriusPoint will recognize a pre-tax gain of $25-30 million. This move is part of SiriusPoint’s strategy to strengthen its partnership with Arcadian and support its growth under the leadership of John Boylan.
The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
On September 29, 2025, SiriusPoint Ltd. announced an agreement to sell its wholly owned supplemental health insurance program manager, ArmadaCare, to Ambac Financial Group Inc. for $250 million. The transaction, expected to close in the fourth quarter of 2025, will result in a pre-tax gain of $220-230 million for SiriusPoint and an increase in its pro-forma tangible book value by approximately 10%. The sale is part of SiriusPoint’s strategy to unlock off-balance sheet value while continuing its capacity partnership with ArmadaCare until 2030, reflecting its strong position in the Accident & Health segment.
The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
On September 3, 2025, SiriusPoint Ltd. announced the appointment of Martin Hudson to its board of directors, effective September 1, 2025. With over 40 years of experience in the (re)insurance industry, Hudson’s leadership spans underwriting, risk management, and executive management across global markets. His appointment is expected to strengthen SiriusPoint’s business and support its growth strategies, delivering long-term value for shareholders and stakeholders.
The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
SiriusPoint Ltd’s recent earnings call painted a picture of a company on a positive trajectory, marked by strong underwriting performance and significant premium growth. The sentiment was buoyed by industry recognition and a series of strategic advancements, despite some challenges such as past losses and foreign exchange impacts. Overall, the tone was optimistic, with highlights outweighing the hurdles faced.
On July 30, 2025, SiriusPoint Ltd. adopted an Executive Severance Plan, effective August 1, 2025, to provide severance payments and benefits to eligible employees in the event of certain employment terminations. The plan outlines specific benefits for executives and other eligible employees, including lump sum payments, full vesting of cash bonuses, and medical benefits. Enhanced benefits are provided if a termination occurs within a year following a change in control, defined by specific criteria such as acquisition of voting securities or board changes.
The most recent analyst rating on (SPNT) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
Siriuspoint Ltd faces significant business risks due to global inflation and the evolving tariff landscape, which could impede its ability to meet business objectives and adversely affect its financial health. Inflation, driven by factors like expansionary monetary policy and supply chain disruptions, can lead to underpricing of insurance risks, necessitating increased loss reserves and reducing net income. Additionally, changing tariffs may slow economic growth, affecting Siriuspoint’s credit and mortgage business, while heightened market volatility could strain its capital and liquidity. Currency fluctuations from inflation may further increase foreign exchange volatility, impacting financial statements.
SiriusPoint Ltd. is a global underwriter of insurance and reinsurance, headquartered in Bermuda, with a presence in key markets like New York, London, and Stockholm. The company specializes in Property & Casualty and Accident & Health insurance and reinsurance, supported by strategic partnerships with Managing General Agents and Program Administrators.
On August 4, 2025, SiriusPoint Ltd. reported its second quarter 2025 financial results, highlighting a significant improvement in its core combined ratio to 89.5%, a 3.8-point improvement from the previous year. The company achieved an 83% year-over-year growth in underwriting income to $68 million and a 10% growth in gross premiums written for its core business. The second quarter return on equity was 12.7%, with underlying earnings per share increasing by 120% from the prior year. SiriusPoint also announced a quarterly cash dividend of $0.50 per share on its Series B preference shares, approved on July 30, 2025. The company was recognized as Program Insurer of the Year in the US, achieved record employee engagement scores, and added new executive leadership members, reinforcing its strategic growth and positioning in the industry.
The most recent analyst rating on (SPNT) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.